tiprankstipranks
Trending News
More News >
Indivior PLC (INDV)
NASDAQ:INDV

Compare Indivior (INDV) vs. Competitors

Compare
190 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Indivior
$35.51
$4.43B
35.35
193.71%
5 Buy
0 Hold
0 Sell
Strong Buy
Neurocrine
$135.57
$13.52B
32.38
-2.26%
18 Buy
3 Hold
0 Sell
Strong Buy
Supernus Pharmaceuticals
$51.17
$2.93B
-150.15
34.45%
5 Buy
1 Hold
0 Sell
Strong Buy
Teva Pharmaceutical
$32.51
$37.89B
53.09
51.28%
10 Buy
1 Hold
0 Sell
Strong Buy
Collegium Pharmaceutical
$48.78
$1.54B
30.36
46.31%
4 Buy
0 Hold
0 Sell
Strong Buy
Amneal Pharmaceuticals
$13.20
$4.15B
929.58
63.77%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INDV
Indivior
35.51
24.00
208.51%
NBIX
Neurocrine
135.57
-7.46
-5.22%
SUPN
Supernus Pharmaceuticals
51.17
13.60
36.20%
TEVA
Teva Pharmaceutical
32.51
12.07
59.05%
COLL
Collegium Pharmaceutical
48.78
14.99
44.36%
AMRX
Amneal Pharmaceuticals
13.20
5.48
70.98%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts